This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burn, A. K.
Right arrow Articles by Redding, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burn, A. K.
Right arrow Articles by Redding, S. W.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2004, p. 5846-5848, Vol. 42, No. 12
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.12.5846-5848.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Comparison of Antifungal Susceptibilities to Fluconazole and Voriconazole of Oral Candida glabrata Isolates from Head and Neck Radiation Patients

A. K. Burn,1* A. W. Fothergill,2,3 W. R. Kirkpatrick,4 B. J. Coco,4 T. F. Patterson,2,4 D. I. McCarthy,2,3 M. G. Rinaldi,2,3 and S. W. Redding1,2

Departments of General Dentistry,1 Pathology,3 Medicine, University of Texas Health Science Center San Antonio,4 South Texas Veterans Healthcare System, San Antonio, Texas2

Received 20 May 2004/ Returned for modification 23 June 2004/ Accepted 2 August 2004

The antifungal susceptibilities of 79 oral Candida glabrata isolates to fluconazole and voriconazole were compared. The MICs at which 90% of the isolates tested were inhibited were 1 µg of voriconazole/ml and 32 µg of fluconazole/ml. Oral C. glabrata isolates for which the fluconazole MICs are elevated are commonly those for which the voriconazole MICs are elevated, but these increases may be transient for voriconazole, as they are for fluconazole.

* Corresponding author. Mailing address: Department of General Dentistry, University of Texas Health Science Center San Antonio, San Antonio, TX 78229. Phone: (210) 535-1740. Fax: (210) 567-3662. E-mail: burn{at}uthscsa.edu.

Journal of Clinical Microbiology, December 2004, p. 5846-5848, Vol. 42, No. 12
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.12.5846-5848.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Panackal, A. A., Gribskov, J. L., Staab, J. F., Kirby, K. A., Rinaldi, M., Marr, K. A. (2006). Clinical Significance of Azole Antifungal Drug Cross-Resistance in Candida glabrata.. J. Clin. Microbiol. 44: 1740-1743 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»